Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Results Submitted status is now shown on the study page, with related topics including Ovarian cancer and MedlinePlus Genetics added, and the revision updated to v3.3.4, replacing No Results Posted and v3.3.3.
    Difference
    0.3%
    Check dated 2026-01-14T02:16:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Explicit related topics 'Ovarian cancer' and 'MedlinePlus Genetics' have been removed from the study page. This reduces explicit disease context and related resource navigation for users seeking ovarian cancer information.
    Difference
    0.2%
    Check dated 2026-01-07T01:28:59.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a new 'Locations' section with California listed as a study site; the old 'California Locations' heading was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:32:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now lists related topics 'Ovarian cancer' and 'MedlinePlus Genetics' in the related topics section. This addition provides cross-references to disease information.
    Difference
    0.2%
    Check dated 2025-12-16T04:44:54.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed related topics links for Ovarian cancer and MedlinePlus Genetics from the Related Topics section.
    Difference
    0.2%
    Check dated 2025-12-09T01:18:32.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Ovarian cancer and MedlinePlus Genetics related topics were added as related topics on the page.
    Difference
    0.2%
    Check dated 2025-12-01T23:10:06.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.